Press Release: New York Times Supplement on Gynecologic Cancers to Provide Critical Women’s Health Information

Chicago, May 8, 2003—Women nationwide will have an opportunity to learn the latest information about gynecologic cancers through a four-page supplement appearing nationwide in The New York Times on Sunday, June 22, 2003. The supplement will also appear Tuesday, June 17 in copies of The New York Times distributed to subscribers in the New York designated market only.

Sponsored by the Gynecologic Cancer Foundation (GCF), the supplement “Gynecologic Cancer—What Every Women Needs to Know,” will provide the latest information regarding risk factors, symptoms, detection methods and treatment options for gynecologic cancers.

“Millions of American women often lack timely and accurate information about testing and treatments for gynecologic cancers,” said Gynecologic Cancer Foundation Chairman Karl C. Podratz, M.D., Ph.D. “This supplement provides one more way for us to further raise awareness about critical women’s health issues. Since education leads to prevention, we believe this supplement can help strengthen our fight against gynecologic cancers.” Dr. Podratz is a professor of Obstetrics and Gynecology at the Mayo Clinic in Rochester, Minn.

The publication date of the GCF supplement was designed to coincide with the annual “Women’s Health” section of The New York Times that will be published on Sunday, June 22, 2003. This Sunday edition of the newspaper has a circulation of 1.7 million and is expected to have a readership of more than 3 million nationwide.

The Gynecologic Cancer Foundation will also distribute more than 10,000 copies of the supplement to members of the Society of Gynecologic Oncologists, women’s health organizations and cancer advocate groups worldwide. Additionally, the supplement will be featured on GCF’s Web site, www.thegcf.org, and the Women’s Cancer Network Web site—the premier site for women’s cancer information—at www.wcn.org.

“After the success of our 2002 supplement which appeared in The Washington Post, we are confident that by providing this important information, we can empower a vast audience of women to take risk-reducing measures when possible, and to seek timely and appropriate medical care should they find themselves experiencing any of the known symptoms for gynecologic cancer,” said Bobbie Gostout, M.D., Communications Chair for the GCF and Assistant Professor, Department of Gynecologic Surgery at the Mayo Clinic.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.